Kevin DeGeeter
Stock Analyst at Ladenburg Thalmann & Co.
(4.72)
# 737
Out of 4,966 analysts
431
Total ratings
38.3%
Success rate
18.8%
Average return
Main Sectors:
Stocks Rated by Kevin DeGeeter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLRB Cellectar Biosciences | Reiterated: Buy | $10 | $2.31 | +332.90% | 14 | Aug 14, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $20 → $12 | $2.05 | +485.37% | 2 | Jun 18, 2026 | |
| TRAW Traws Pharma | Downgraded: Hold | n/a | $0.5643 | - | 2 | Jun 15, 2026 | |
| URGN UroGen Pharma | Initiated Coverage: Buy | $43 | $42.31 | +1.63% | 1 | May 11, 2026 | |
| DCOY Decoy Therapeutics | Initiated Coverage: Buy | $2.5 | $2.67 | -6.37% | 1 | Jan 23, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $15 | $12.04 | +24.58% | 21 | Nov 14, 2025 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $19 | $1.21 | +1,470.25% | 2 | Nov 10, 2025 | |
| NXTC NextCure | Upgraded: Buy | $18 | $7.00 | +157.14% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Reiterated: Buy | $5.2 → $3 | $1.57 | +91.08% | 10 | Oct 30, 2025 | |
| NVCR NovoCure | Initiated Coverage: Buy | $98 → $30 | $15.79 | n/a | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $5.41 | n/a | 1 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $59 | $54.21 | n/a | 18 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $37 | $5.02 | n/a | 9 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7 | $0.0001 | n/a | 13 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $2.03 | n/a | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $24 | $16.21 | n/a | 21 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $141 → $125 | $20.03 | n/a | 20 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.22 | n/a | 19 | Dec 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $5 | $0.000001 | n/a | 8 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.13 | n/a | 23 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.04 | n/a | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $13.40 | n/a | 16 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.715 | n/a | 18 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.13 | n/a | 6 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $37.55 | n/a | 24 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $37.44 | n/a | 6 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $37.59 | n/a | 20 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.00001 | n/a | 21 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.22 | n/a | 1 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.872 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.88 | n/a | 13 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.35 | n/a | 9 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.50 | n/a | 7 | Nov 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.42 | n/a | 22 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.83 | n/a | 12 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.01 | n/a | 7 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.000001 | n/a | 1 | Jul 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $7.5 | $9.23 | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $15.43 | n/a | 2 | Apr 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.485 | n/a | 2 | Feb 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $3.42 | n/a | 6 | Feb 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.47 | n/a | 1 | Jan 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.09 | n/a | 5 | Dec 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 3 | Nov 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $45 | $1.38 | n/a | 1 | Oct 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $121.47 | n/a | 9 | Oct 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.13 | n/a | 4 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $121 | $377.35 | n/a | 2 | Apr 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.12 | n/a | 1 | Feb 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $143.72 | n/a | 2 | Jan 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $3 | $0.0001 | n/a | 2 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0008 | n/a | 1 | Oct 1, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.75 → $2.75 | $0.0001 | n/a | 2 | Aug 8, 2013 |
Cellectar Biosciences
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Elicio Therapeutics
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $20 → $12
Current: $2.05
Upside: +485.37%
Traws Pharma
Jun 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.5643
Upside: -
UroGen Pharma
May 11, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $42.31
Upside: +1.63%
Decoy Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $2.5
Current: $2.67
Upside: -6.37%
ORIC Pharmaceuticals
Nov 14, 2025
Reiterated: Buy
Price Target: $15
Current: $12.04
Upside: +24.58%
Cardiff Oncology
Nov 10, 2025
Reiterated: Buy
Price Target: $19
Current: $1.21
Upside: +1,470.25%
NextCure
Nov 7, 2025
Upgraded: Buy
Price Target: $18
Current: $7.00
Upside: +157.14%
OPKO Health
Oct 30, 2025
Reiterated: Buy
Price Target: $5.2 → $3
Current: $1.57
Upside: +91.08%
NovoCure
Jul 8, 2025
Initiated Coverage: Buy
Price Target: $98 → $30
Current: $15.79
Upside: n/a
Apr 19, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $5.41
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: $63 → $59
Current: $54.21
Upside: n/a
Apr 1, 2022
Reiterated: Buy
Price Target: $45 → $37
Current: $5.02
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $9 → $7
Current: $0.0001
Upside: n/a
Mar 30, 2022
Reiterated: Buy
Price Target: $19 → $17
Current: $2.03
Upside: n/a
Feb 25, 2022
Reiterated: Buy
Price Target: $30 → $24
Current: $16.21
Upside: n/a
Jan 25, 2022
Reiterated: Buy
Price Target: $141 → $125
Current: $20.03
Upside: n/a
Dec 27, 2021
Reiterated: Buy
Price Target: $14
Current: $1.22
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $5.5 → $5
Current: $0.000001
Upside: n/a
Oct 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Sep 20, 2021
Initiated Coverage: Buy
Price Target: $30
Current: $4.04
Upside: n/a
Jul 20, 2021
Reiterated: Buy
Price Target: $7
Current: $13.40
Upside: n/a
Jul 13, 2021
Reiterated: Buy
Price Target: $18
Current: $0.715
Upside: n/a
Jul 8, 2021
Reiterated: Buy
Price Target: $18
Current: $3.13
Upside: n/a
Jun 30, 2021
Reiterated: Hold
Price Target: n/a
Current: $37.55
Upside: n/a
Jun 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $37.44
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $25
Current: $37.59
Upside: n/a
Jun 16, 2021
Reiterated: Buy
Price Target: $5.5
Current: $0.00001
Upside: n/a
May 26, 2021
Initiated Coverage: Buy
Price Target: $25
Current: $4.22
Upside: n/a
Apr 29, 2021
Initiated Coverage: Buy
Price Target: $17
Current: $0.872
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $9.88
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $3.35
Upside: n/a
Nov 25, 2020
Rated: Hold
Price Target: n/a
Current: $6.50
Upside: n/a
Jun 15, 2020
Rated: Hold
Price Target: n/a
Current: $9.42
Upside: n/a
Feb 24, 2020
Rated: Hold
Price Target: n/a
Current: $6.83
Upside: n/a
May 9, 2019
Rated: Buy
Price Target: $3
Current: $1.01
Upside: n/a
Jul 10, 2018
Initiated Coverage: Buy
Price Target: $3
Current: $0.000001
Upside: n/a
Jun 13, 2018
Reiterated: Buy
Price Target: $13 → $7.5
Current: $9.23
Upside: n/a
Apr 10, 2017
Reiterated: Buy
Price Target: $13
Current: $15.43
Upside: n/a
Feb 14, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.485
Upside: n/a
Feb 8, 2017
Upgraded: Hold
Price Target: n/a
Current: $3.42
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: n/a
Current: $1.47
Upside: n/a
Dec 15, 2014
Rated: Hold
Price Target: n/a
Current: $37.09
Upside: n/a
Nov 13, 2014
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 31, 2014
Rated: Sell
Price Target: $45
Current: $1.38
Upside: n/a
Oct 30, 2014
Rated: Buy
Price Target: $75
Current: $121.47
Upside: n/a
Aug 7, 2014
Rated: Buy
Price Target: $3
Current: $1.13
Upside: n/a
Apr 4, 2014
Rated: Hold
Price Target: $121
Current: $377.35
Upside: n/a
Feb 28, 2014
Initiated Coverage: Hold
Price Target: n/a
Current: $8.12
Upside: n/a
Jan 26, 2014
Rated: Buy
Price Target: $86
Current: $143.72
Upside: n/a
Nov 7, 2013
Reiterated: Buy
Price Target: $7.5 → $3
Current: $0.0001
Upside: n/a
Oct 1, 2013
Upgraded: Buy
Price Target: n/a
Current: $0.0008
Upside: n/a
Aug 8, 2013
Reiterated: Buy
Price Target: $1.75 → $2.75
Current: $0.0001
Upside: n/a